Ambient

Monoethanolamine Hydrochloride

Monoethanolamine, NF

Monoethanolamine, NF

Monoethanolamine, NF

Monoethanolamine, NF

GenScript’s Monofinity A Resin is made of recombinant protein A as ligand, which not only keeps the specific binding capacity to Fc region of immunoglobulin molecules, but also enhances chemical stability under Cleaning-in-place (CIP) conditions.

GenScript’s Monofinity A Resin is made of recombinant protein A as ligand, which not only keeps the specific binding capacity to Fc region of immunoglobulin molecules, but also enhances chemical stability under Cleaning-in-place (CIP) conditions.

GenScript’s Monofinity A Resin is made of recombinant protein A as ligand, which not only keeps the specific binding capacity to Fc region of immunoglobulin molecules, but also enhances chemical stability under Cleaning-in-place (CIP) conditions.

Protein A affinity chromatography resin is the most commonly applied method for the isolation and purification of IgG. Protein A is a cell wall component found in several strains of Staphylococcus aureus. It has five high affinity binding sites capable of binding specifically to the Fc region of immunoglobulin molecules from several species. Covalently immobilized Protein A matrices have been extensively used to purify IgG from several species of mammals.

GenScript’s Monofinity A Resin is made of recombinant protein A as ligand, which not only keeps the specific binding capacity to Fc region of immunoglobulin molecules, but also enhances chemical stability under Cleaning-in-place (CIP) conditions. The typical dynamic binding capacity is more than 30 g human IgG/L settled resin. There is no significant decrease of binding capacity after purification/CIP for 200 cycles. In the meanwhile, the Monofinity A Resin has a low leakage of ligand (< 15 ng ligand/mg IgG) over a number of purification/CIP cycles.

As a high quality antibody purification resin, it is highly suitable for large scale antibody purification, and meets the purification requirements of industry-scale customers.

Product Details 

Protein A affinity chromatography resin is the most commonly applied method for the isolation and purification of IgG. Protein A is a cell wall component found in several strains of Staphylococcus aureus. It has five high affinity binding sites capable of binding specifically to the Fc region of immunoglobulin molecules from several species. Covalently immobilized Protein A matrices have been extensively used to purify IgG from several species of mammals.

GenScript’s Monofinity A Resin is made of recombinant protein A as ligand, which not only keeps the specific binding capacity to Fc region of immunoglobulin molecules, but also enhances chemical stability under Cleaning-in-place (CIP) conditions. The typical dynamic binding capacity is more than 30 g human IgG/L settled resin. There is no significant decrease of binding capacity after purification/CIP for 200 cycles. In the meanwhile, the Monofinity A Resin has a low leakage of ligand (< 15 ng ligand/mg IgG) over a number of purification/CIP cycles.

As a high quality antibody purification resin, it is highly suitable for large scale antibody purification, and meets the purification requirements of industry-scale customers.

Product Details 

Protein A affinity chromatography resin is the most commonly applied method for the isolation and purification of IgG. Protein A is a cell wall component found in several strains of Staphylococcus aureus. It has five high affinity binding sites capable of binding specifically to the Fc region of immunoglobulin molecules from several species. Covalently immobilized Protein A matrices have been extensively used to purify IgG from several species of mammals.

GenScript’s Monofinity A Resin is made of recombinant protein A as ligand, which not only keeps the specific binding capacity to Fc region of immunoglobulin molecules, but also enhances chemical stability under Cleaning-in-place (CIP) conditions. The typical dynamic binding capacity is more than 30 g human IgG/L settled resin. There is no significant decrease of binding capacity after purification/CIP for 200 cycles. In the meanwhile, the Monofinity A Resin has a low leakage of ligand (< 15 ng ligand/mg IgG) over a number of purification/CIP cycles.

As a high quality antibody purification resin, it is highly suitable for large scale antibody purification, and meets the purification requirements of industry-scale customers.

Product Details 

Protein A affinity chromatography resin is the most commonly applied method for the isolation and purification of IgG. Protein A is a cell wall component found in several strains of Staphylococcus aureus. It has five high affinity binding sites capable of binding specifically to the Fc region of immunoglobulin molecules from several species. Covalently immobilized Protein A matrices have been extensively used to purify IgG from several species of mammals.

GenScript’s Monofinity A Resin is made of recombinant protein A as ligand, which not only keeps the specific binding capacity to Fc region of immunoglobulin molecules, but also enhances chemical stability under Cleaning-in-place (CIP) conditions. The typical dynamic binding capacity is more than 30 g human IgG/L settled resin. There is no significant decrease of binding capacity after purification/CIP for 200 cycles. In the meanwhile, the Monofinity A Resin has a low leakage of ligand (< 15 ng ligand/mg IgG) over a number of purification/CIP cycles.

As a high quality antibody purification resin, it is highly suitable for large scale antibody purification, and meets the purification requirements of industry-scale customers.

Product Details 

Monolaurin

Monolaurin

Monomethyl Fumarate

Monomethyl Fumarate

Monomethyl Itaconate

Monomethyl Itaconate

Monomethyl Maleate

Monomethyl Maleate

Monomethyl Maleate

Monopalmitin

GenScript MonoRab^TM Anti-DYKDDDDK Magnetic Beads are super paramagnetic beads with diameter of 70
μm, covalently coated with a rabbit monoclonal anti-DYKDDDDK antibody. The beads are supplied as 50%
slurry in TBS with 50% glycerol and 0.02% sodium azide. The MonoRab^TM Anti-DYKDDDDK Magnetic Beads
have a binding capacity of 1.5 mg DYKDDDDK-tagged protein (Size: 50KDa) per 1 ml settled beads. The beads
can be re-used for at least 5 times.
Based on our new rabbit monoclonal antibody technology (MonoRab^TM), this beads offers high binding
capacity, high purity, and withstand stringent washing steps, especially with buffers containing high
concentration of salt. The beads are resistant to up to 2 M NaCl, and to buffers with pH as low as 2.5.

GenScript MonoRab^TM Anti-DYKDDDDK Magnetic Beads are super paramagnetic beads with diameter of 70
μm, covalently coated with a rabbit monoclonal anti-DYKDDDDK antibody. The beads are supplied as 50%
slurry in TBS with 50% glycerol and 0.02% sodium azide. The MonoRab^TM Anti-DYKDDDDK Magnetic Beads
have a binding capacity of 1.5 mg DYKDDDDK-tagged protein (Size: 50KDa) per 1 ml settled beads. The beads
can be re-used for at least 5 times.
Based on our new rabbit monoclonal antibody technology (MonoRab^TM), this beads offers high binding
capacity, high purity, and withstand stringent washing steps, especially with buffers containing high
concentration of salt. The beads are resistant to up to 2 M NaCl, and to buffers with pH as low as 2.5.

GenScript MonoRab^TM Anti-DYKDDDDK Magnetic Beads are super paramagnetic beads with diameter of 70
μm, covalently coated with a rabbit monoclonal anti-DYKDDDDK antibody. The beads are supplied as 50%
slurry in TBS with 50% glycerol and 0.02% sodium azide. The MonoRab^TM Anti-DYKDDDDK Magnetic Beads
have a binding capacity of 1.5 mg DYKDDDDK-tagged protein (Size: 50KDa) per 1 ml settled beads. The beads
can be re-used for at least 5 times.
Based on our new rabbit monoclonal antibody technology (MonoRab^TM), this beads offers high binding
capacity, high purity, and withstand stringent washing steps, especially with buffers containing high
concentration of salt. The beads are resistant to up to 2 M NaCl, and to buffers with pH as low as 2.5.

Adeno-associated virus type 2 (AAV2) is a valuable vector for gene therapy. It is one member of the human parvovirus family which depends on co-infection with helper viruses such as adenovirus or herpes virus for efficient reproduction. AAV2 empty capsids are composed of three proteins, VP1, VP2 and VP3 with relative molecular masses of 87, 72 and 62 kDa, respectively.

Adeno-associated virus type 2 (AAV2) is a valuable vector for gene therapy. It is one member of the human parvovirus family which depends on co-infection with helper viruses such as adenovirus or herpes virus for efficient reproduction. AAV2 empty capsids are composed of three proteins, VP1, VP2 and VP3 with relative molecular masses of 87, 72 and 62 kDa, respectively.

Adeno-associated virus type 8 (AAV8) is a valuable vector for gene therapy. It is one member of the human parvovirus family which depends on co-infection with helper viruses such as adenovirus or herpes virus for efficient reproduction. AAV2 empty capsids are composed of three proteins, VP1, VP2 and VP3 with relative molecular masses of 87, 72 and 62 kDa, respectively.

Adeno-associated virus type 8 (AAV8) is a valuable vector for gene therapy. It is one member of the human parvovirus family which depends on co-infection with helper viruses such as adenovirus or herpes virus for efficient reproduction. AAV2 empty capsids are composed of three proteins, VP1, VP2 and VP3 with relative molecular masses of 87, 72 and 62 kDa, respectively.

The monoclonal antibody 24F5 react with the AAV capsid protein VP1. The antibody is suitable for application in western blot analysis due to their reactivity with linear epitopes present in the dentaured protein sequence of VP1 proteins

The monoclonal antibody 5G4 react with the three AAV capsid proteins VP1, VP2 and VP3. The antibody is suitable for application in western blot analysis due to their reactivity with linear epitopes present in the dentaured protein sequence of all three proteins.

The product is specific for Adalimumab. This antibody blocks Adalimumab binding with TNF-α (Z01001, TNF-α, Human) in ELISA. The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01921-40, MonoRab™ Anti-Adalimumab Antibody (4E12), mAb, Rabbit.

The product is specific for Adalimumab. This antibody blocks Adalimumab binding with TNF-α (Z01001, TNF-α, Human) in ELISA. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01922-40, MonoRabTM Anti-Adalimumab Antibody (134D5), mAb, Rabbit.

The antibody is recommended as detection antibody in a pharmacokinetic (PK) bridging assay with captrue antibody GenScript, A01984-40, MonoRab Anti-Atezolizumab Antibody (55D8), mAb, Rabbit.

The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01984-40, MonoRab Anti-Atezolizumab Antibody (55D8), mAb, Rabbit.

The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01985-40, MonoRab Anti-Atezolizumab Antibody (43H11), mAb, Rabbit.

The product is specific for Bevacizumab but can’t block vascular endothelial growth factor 165 (VEGF 165). The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01896-40, MonoRabTM Anti- Bevacizumab Antibody (46E3)[Biotin], mAb, Rabbit.

The product is specific for Bevacizumab. This antibody blocks Bevacizumab binding with VEGF165 (Z02689, VEGF165, Human). The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01895-40, MonoRab Anti-Bevacizumab Antibody (30E1), mAb, Rabbit.

The product is specific for Bevacizumab. This antibody blocks Bevacizumab binding with VEGF165 (Z02689, VEGF165, Human). The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01895-40, MonoRabTM Anti-Bevacizumab Antibody (30E1), mAb, Rabbit.

Camelid
VHH Antibody (also called single-domain antibody, sdAb or Nanobody by Ablynx)
is a peptide chain about 110 amino acids in length, containing one variable domain
of a heavy-chain antibody (a VHH fragment). Like a whole antibody, the camelid
VHH antibody is able to bind selectively to a specific antigen. This single-domain
antibody has a broad range of applications in biotechnical and therapeutic research
fields due to its small size, simple production and high affinity.
GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin (Cat. No. L00905) is designed for purification of Camelid VHH
single domain antibody from commonly used protein expression systems such as bacteria,
yeast and mammalian cells. The VHH single domain antibody in cell lysate can specifically
bind to the Anti-Camelid VHH monoclonal antibody coupled to the resin. Nonspecific
binding reactions are eliminated by stringent washing steps, and the purified Camelid
VHH single domain antibody is eluted with a high recovery rate. Table
1 lists the main characteristics of GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin.

 Table 1. Characteristics of Anti-Camelid VHH Affinity
Resin

Camelid
VHH Antibody (also called single-domain antibody, sdAb or Nanobody by Ablynx)
is a peptide chain about 110 amino acids in length, containing one variable domain
of a heavy-chain antibody (a VHH fragment). Like a whole antibody, the camelid
VHH antibody is able to bind selectively to a specific antigen. This single-domain
antibody has a broad range of applications in biotechnical and therapeutic research
fields due to its small size, simple production and high affinity.
GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin (Cat. No. L00905) is designed for purification of Camelid VHH
single domain antibody from commonly used protein expression systems such as bacteria,
yeast and mammalian cells. The VHH single domain antibody in cell lysate can specifically
bind to the Anti-Camelid VHH monoclonal antibody coupled to the resin. Nonspecific
binding reactions are eliminated by stringent washing steps, and the purified Camelid
VHH single domain antibody is eluted with a high recovery rate. Table
1 lists the main characteristics of GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin.

 Table 1. Characteristics of Anti-Camelid VHH Affinity
Resin

Camelid
VHH Antibody (also called single-domain antibody, sdAb or Nanobody by Ablynx)
is a peptide chain about 110 amino acids in length, containing one variable domain
of a heavy-chain antibody (a VHH fragment). Like a whole antibody, the camelid
VHH antibody is able to bind selectively to a specific antigen. This single-domain
antibody has a broad range of applications in biotechnical and therapeutic research
fields due to its small size, simple production and high affinity.
GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin (Cat. No. L00905) is designed for purification of Camelid VHH
single domain antibody from commonly used protein expression systems such as bacteria,
yeast and mammalian cells. The VHH single domain antibody in cell lysate can specifically
bind to the Anti-Camelid VHH monoclonal antibody coupled to the resin. Nonspecific
binding reactions are eliminated by stringent washing steps, and the purified Camelid
VHH single domain antibody is eluted with a high recovery rate. Table
1 lists the main characteristics of GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin.

 Table 1. Characteristics of Anti-Camelid VHH Affinity
Resin

Camelid
VHH Antibody (also called single-domain antibody, sdAb or Nanobody by Ablynx)
is a peptide chain about 110 amino acids in length, containing one variable domain
of a heavy-chain antibody (a VHH fragment). Like a whole antibody, the camelid
VHH antibody is able to bind selectively to a specific antigen. This single-domain
antibody has a broad range of applications in biotechnical and therapeutic research
fields due to its small size, simple production and high affinity.
GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin (Cat. No. L00905) is designed for purification of Camelid VHH
single domain antibody from commonly used protein expression systems such as bacteria,
yeast and mammalian cells. The VHH single domain antibody in cell lysate can specifically
bind to the Anti-Camelid VHH monoclonal antibody coupled to the resin. Nonspecific
binding reactions are eliminated by stringent washing steps, and the purified Camelid
VHH single domain antibody is eluted with a high recovery rate. Table
1 lists the main characteristics of GenScript’s MonoRab™ Anti-Camelid VHH
Affinity Resin.

 Table 1. Characteristics of Anti-Camelid VHH Affinity
Resin

This product is specific for Certolizumab pegol.

This product is specific for Certolizumab pegol.

The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01992-40, MonoRab™ Anti-Cetuximab Antibody (90G3), mAb, Rabbit.

The antibody is recommended as a detection antibody in a pharmacokinetic (PK) bridging assay with capture antibody GenScript, A01991-40, MonoRab™ Anti-Cetuximab Antibody (69H10), mAb, Rabbit.

The product is specific for Daratumumab.